Why Pharma Giants Like Varda Are Growing Cancer Drug Crystals in Orbit

California-based Varda Space Industries has hit a milestone with three washing machine-sized capsules now orbiting Earth simultaneously. Inside one, tiny crystals of a potential cancer drug are being cultivated in microgravity, while the other two are testing heat shields and navigation for hypersonic re-entry. This marks a significant step toward a possible new industry: manufacturing pharmaceuticals and materials in space, where the absence of gravity can yield purer, more uniform crystal structures than on Earth. Varda launched two capsules on October 1 and a third on October 20, edging closer to a fleet of orbiting drug factories. The company’s approach could eventually produce higher-quality cancer treatments and other therapies, potentially reducing costs and improving patient outcomes. For the pharmaceutical sector, space manufacturing offers a novel way to overcome limitations of terrestrial production. As Varda refines its re-entry and recovery systems, the coming months will reveal whether orbital drug manufacturing can scale from experiment to commercial reality.